Patents by Inventor Debra Zack

Debra Zack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220389098
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Application
    Filed: May 16, 2022
    Publication date: December 8, 2022
    Applicant: Xencor, Inc.
    Inventors: Debra Zack, John H. Stone, Shiv Pillai, Paul Foster
  • Patent number: 11365256
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 21, 2022
    Assignee: XENCOR, INC.
    Inventors: Debra Zack, John H. Stone, Shiv Pillai, Paul Foster
  • Publication number: 20170355766
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Application
    Filed: June 8, 2017
    Publication date: December 14, 2017
    Applicant: Xencor, Inc.
    Inventors: Debra Zack, John H. Stone, Shiv Patel, Paul Foster